throbber
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`HARVEST TRADING GROUP, INC.,
`Petition
`
`v.
`
`VIREO SYSTEMS, INC. AND
`UNEMED CORPORATION,
`
`Patent Owners
`
`U.S. PATENT NO. 8,354,450
`IPR 2016-00945
`
`U.S. PATENT NO. 8,962,685
`IPR 2016-00947
`
`DECLARATION OF JASON WIGGERS
`
`Exhibit 2012
`
`
`
`
`
`
`
`
`
`Vireo Systems, Inc. Ex. 2012 – 001
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`DECLARATION
`
`I, Jason Wiggers, hereby declare and say:
`
`1.
`
`I am over the age of eighteen (18) and have personal knowledge of the
`
`matters set forth herein.
`
`2.
`
`I am the Operations Manager of Vireo Systems, Inc. (“Vireo”). I have
`
`held this position since November 2007. My job responsibilities include overseeing
`
`of operations, which include but are not limited to research and development,
`
`manufacturing, and product development. I have 9 years of laboratory and
`
`commercial scale supplement and drug manufacturing experience. I have a
`
`bachelor’s degree in Biology with a minor in Chemistry at David Lipscomb
`
`University from 2004.
`
`3.
`
`Vireo is one of the co-owners of U.S. Patent Nos. 8,354,450 (the “
`
`‘450 Patent”), 8,962,685 (the “ ‘685 Patent”), 8,026,385 (the “ ‘385 Patent”), and
`
`7,608,641 (the “ ‘641 Patent).
`
`4.
`
`I understand that the ‘450 Patent is subject to a petition for inter partes
`
`review in Proceeding No. IPR2016-00945, and that the ‘685 Patent is subject to a
`
`petition for inter partes review in Proceeding No. IPR2016-00947. I further
`
`understand that the ‘450 Patent is identified as a continuation in part of the ‘385
`
`Patent, and the ‘385 Patent is a continuation of the ‘641. I further understand and
`
`that the ‘685 Patent is a divisional of the ‘450 Patent.
`
`Vireo Systems, Inc. Ex. 2012 – 002
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`5.
`
`I was requested by Vireo’s counsel to prepare samples of creatine
`
`hydrochloride according to the methods described in the ‘641 Patent. I have
`
`reviewed the ‘641 Patent and am familiar with the procedures that it describes.
`
`6.
`
`To conduct the procedures, I supervised the work performed by
`
`Vireo-trained personnel. I specified the procedures used and am personally familiar
`
`with the testing, and I can testify to such if called to do so. The procedures
`
`performed under my supervision for purposes of the requested creatine
`
`hydrochloride preparation are attached hereto as Exhibit A.
`
`Method 1: Acetyl Chloride Mixture.
`
`7.
`
`The first procedure for preparing creatine hydrochloride is described
`
`in lines 4-14 of column 3 of the ‘641 Patent, using the following steps. First,
`
`creatine monohydrate is blended with acetyl chloride in a vessel. Ethanol is added
`
`to the vessel to dissolve the blended mixture. The temperature of the solution is
`
`raised to be between 24° C and 50° C. The ‘641 Patent specifically discloses that
`
`25° C is preferred. At these conditions, creatine hydrochloride salt precipitates in a
`
`granular form. These granules may then be collected and packaged for
`
`consumption.
`
`8.
`
`In order to conduct this procedure, I directed that 8.89 grams (0.059
`
`mol) of creatine monohydrate be weighed out and placed into an Erlenmeyer flask.
`
`6 ml (0.084 mol) of acetyl chloride were measured in a 10 ml graduated cylinder.
`
`Vireo Systems, Inc. Ex. 2012 – 003
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`These weights equal the molar ratio of 1:1.4 described in the ‘641 Patent at column
`
`2, lines 53-56. In addition, 10 ml of SDA-35A ethanol were measured out in a 10
`
`ml graduated cylinder for dissolving, as instructed in the ‘641 Patent at column 2,
`
`lines 60-61. See Exhibit A, at p. 3.
`
`9.
`
`The reaction is exothermic. The ‘641 Patent, at column 2, lines 63-67,
`
`instructs that temperature should be maintained below 50° C to reduce the amount
`
`of creatinine hydrochloride and creatine ethyl ester hydrochloride contaminants
`
`produced by the reaction. Therefore, in order to stay within the instructed
`
`temperature range and minimize the impact of the heat energy associated with the
`
`reaction, I directed that the vessel containing the reactants be placed in an ice bath
`
`to manage or regulate the temperature of the reaction. This is a common and
`
`standard laboratory technique. The initial temperature was measured to be 14° C.
`
`Next, the acetyl chloride was poured into the flask and stirred to ensure a complete
`
`mixture. Due to the exothermic reaction, the temperature was then measured to be
`
`41° C, that is, within the directed temperature range of the ‘641 Patent. The ethanol
`
`was then added to dissolve the mixture. As the reaction continued, a slurry formed
`
`from the resulting precipitated salt. See Exhibit A, at p. 3.
`
`10.
`
`Once the temperature reached a steady 25° C, the slurry was emptied
`
`onto a sterile filter paper in accordance with standard procedures for isolating a
`
`precipitated compound. Additional ethanol was used to wash the precipitate. The
`
`Vireo Systems, Inc. Ex. 2012 – 004
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`excess liquid was removed, and then the entire composition was set to air dry at
`
`room temperature for 3 hours. The final sample product measured 11 grams. See
`
`Exhibit A, at p. 3.
`
`11.
`
`I directed that 100 mg of the dried sample be isolated in sterile
`
`packaging for pick up and transport by Samir Saleh for purity testing, and that 5 g
`
`of the dried sample be used for testing solubility as described further below.
`
`Method 2: HCl Gas Infusion
`
`12.
`
`The second procedure for preparing creatine hydrochloride is
`
`described in lines 15-28 of column 3 of the ‘641 Patent, using the following steps.
`
`A diethyl ether solvent is provided, into which gaseous hydrochloride is bubbled.
`
`Creatine monohydrate is then stirred into the diethyl ether solvent. This results in a
`
`creatine hydrochloride precipitate. The precipitate is filtered and washed using
`
`fresh diethyl ether. The precipitate is then dried to isolate the creatine
`
`hydrochloride and collect it for consumption. The ‘641 Patent teaches that there
`
`can be a range of concentrations of gaseous hydrochloride, so long as it exceeds
`
`the molar equivalent of the creatine monohydrate to be added to the solvent.
`
`13.
`
`In order to conduct this procedure, I directed that 5 ml of diethyl ether
`
`be poured into an Erlenmeyer flask, and 4.45 g of creatine monohydrate be
`
`measured out. Tubing for bubbling in gaseous hydrochloride was threaded into the
`
`flask and submerged in the ether. The entire apparatus was placed in the fume
`
`Vireo Systems, Inc. Ex. 2012 – 005
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`hood, and then 1.5 g of gas was bubbled into the ether. Once the tubing was
`
`removed, the creatine monohydrate was incrementally added to the ether-gas
`
`mixture and stirred while monitoring the temperature. The temperature reached a
`
`maximum of 38° C. After stabilization, the slurry was poured onto filter paper in
`
`order to recover the precipitate and washed with an additional 5 ml of ether. After
`
`excess liquid was removed, the precipitate was set to dry for 3 hours at room
`
`temperature to provide a dry sample. See Exhibit A, at pp. 4-5.
`
`14.
`
`I directed that 100 mg of the dried sample be isolated in sterile
`
`packaging for pick up and transport by Samir Saleh for purity testing, and that 5 g
`
`of the dried sample be used for testing solubility as described further below.
`
`Solubility Testing
`
`15.
`
`After the samples produced by Methods 1 and 2 were prepared, I
`
`directed that the solubility of the samples be tested. The procedure for solubility
`
`testing is set forth in Exhibit A, at p. 6.
`
`16.
`
`For each sample, 3.75 g of creatine HCl was weighed out and crushed
`
`into a very fine powder. This was then combined with 5 ml of purified water in a
`
`50 ml beaker. The solution was stirred for 2 minutes to achieve equilibrium. The
`
`solution was then poured over filter paper placed in a funnel, and the funnel was
`
`attached to a vacuum that emptied into a 500 ml Buchner flask. When the vacuum
`
`was activated, the liquid was pulled into the Buchner flask, leaving wet insolubles
`
`Vireo Systems, Inc. Ex. 2012 – 006
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`on the filter paper. The sample was air dried, then scraped onto measuring paper
`
`and weighed.
`
`17.
`
`To find the solubility, the amount of dried insoluble material is
`
`deducted from the total amount of the sample, and that result is divided by the
`
`amount of water. This is a standard way to measure solubility of a substance. The
`
`formula is as follows:
`
`((Original Sample Mass) – (Mass of Insoluble Remainder)) / (Volume of Water)
` = Aqueous Solubility
`
`18.
`
`For sample 1, the insoluble remainder had a mass of 0.09 g. This
`
`demonstrated that sample 1 had a solubility of 732 mg/ml, using the calculation of
`
`(3.75 g – 0.09 g) / 5 ml = 0.732 g/ml = 732 mg/ml.
`
`19.
`
`For sample 2, the insoluble remainder had a mass of 0.43 g. This
`
`demonstrated that sample 1 had a solubility of 664 mg/ml, using the calculation of
`
`(3.75 g – 0.43 g) / 5 ml = 0.664 g/ml = 664 mg/ml.
`
`Transport of Samples to Samir Saleh
`
`20.
`
`For samples picked up and transported by Saleh for purity testing, the
`
`samples were transferred in a sterile manner into sterilized packaging and sealed.
`
`The person making the transfer and myself then executed the chain of custody
`
`forms. Mr. Saleh picked up the sealed samples from the office/lab, as demonstrated
`
`on the chain of custody form attached hereto as Exhibit B.
`
`Conclusion
`
`Vireo Systems, Inc. Ex. 2012 – 007
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`Vireo Systems, Inc. Ex. 2012 – 008
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`EXHIBIT A TO EX. 2012
`
`Vireo Systems, Inc.
`
`Vireo Systems, Inc.
`
`Patent #7,608,641
`
` 6/20/2016
`
`Vireo Systems, Inc. Ex. 2012 – 009
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`Vireo Systems, Inc.
`
`Method of Manufacture 1: Acetyl Chloride
`
`Raw Materials:
`20 gram of Acetyl Chloride ( 18ml) sourced from Fluka Analytical, Lot #BCBM0208V
`30 gram of Creatine Monohydrate manufactured by Shanghai Baosui Co. Ltd, Batch #20150209
`30 ml of Ethanol SDA-35A from Superior Chemicals & Solvents, Lot #AK6372719
`
`Equipment:
`Ice
`Vacuum Filter System (vacuum pump, plastic perforated funnel, filter paper medium, 500 ml Buchner
`Flask)
`Ring stand and clamps
`50 ml Pyrex Beakers
`500 ml Pyrex Beaker
`125 ml Pyrex Erlenmeyer Flasks
`Highland HCB 1002 Balance
`Calibrated Accu-Safe 12" Lab Thermometer (0 - 230 ℉)
`Paper measuring tray
`10 ml Pyrex Graduated Cylinders
`Clock / Timer
`Glass Stir Rod
`Plastic Scraper
`
`Foreword:
`In processing this method of manufacturing the raw materials , samples 1 utilized a 1:1.4 ratio of
`Creatine Monohydrate to Acetyl Chloride by mole. Samples 1 was synthesized via Acetyl Chloride as
`chosen Acid Catalyst. This method detailed in Patent #7,608,641 has been shown to produce creatine
`hydrochloride.
`
`Sample 1: 1 mol CH20: 1.4 mol Acetyl Chloride
`Ethanol was added in all at once
`
`Vireo Systems, Inc. Ex. 2012 – 010
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`Vireo Systems, Inc.
`
`Procedure for Sample 1:
`1. Placed paper measuring tray on Balance and tared out weight
`2. Weighed Out 8.89 gram of Creatine Monohydrate
`3. Measured out 10 ml of SDA-35A in 10 ml graduated cylinder
`4. Measured 6 ml of Acetyl Chloride in 10 ml graduated cylinder
`5. Placed Creatine Monohydrate into 125 ml erlenmeyer flask
`6. Fill 500 ml beaker halfway with ice and water to create ice bath
`7. Submerged in ice bath and secure to ring stand
`8. Took Temperature ( 14℃)
`9. Poured in 6 ml of Acetyl Chloride
`10. Stirred for 1 min
`11. Took Temperature Measurement (41℃)
`12. Added Ethanol SDA-35A (10ml)
`13. Stirred for 2 min
`14. Waited for Temperature to reach 25 ℃ (approximately 2 minutes)
`15. Placed filter paper into vacuum filter system
`16. Emptied reacted slurry onto filter paper
`17. Washed slurry with 5 ml of Ethanol SDA-35A
`18. Turned on vacuum and maximized exposed surface area and waited until liquid excretion halted
`19. Removed filter paper with sample containing precipitates from vacuum filter system
`20. Set in controlled environment to air dry for 3 hours at room temperature
`21. Transferred sample to paper measuring tray
`22. Weighed Final Sample Product (11 gram) taring out paper measuring tray weight
`
`Final product was found via NMR spectroscopy to be at least 98 percent or greater pure creatine
`hydrochloride.
`
`Samples were prepared in sterile packaging for transport to Vanderbilt for purity testing.
`
`Vireo Systems, Inc. Ex. 2012 – 011
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`Vireo Systems, Inc.
`
`Method of Manufacture 2: HCl gas infusion
`
`Raw Materials:
`10 gram Creatine Monohydrate manufactured by Shanghai Baosui Co. Ltd, Batch #20150209
`3 gram HCl gas (from 60 lb Linde Electronics and Specialty Gases Tank)
`20 ml Diethyl Ether sourced from Fisher Scientific
`
`Equipment:
`Ice
`Vacuum Filter System (vacuum pump, plastic perforated funnel, filter paper medium, 500 ml Buchner
`Flask)
`Ring stand and clamps
`50 ml Pyrex Beakers
`500 ml Pyrex Beaker
`125 ml Pyrex Erlenmeyer Flasks
`Highland HCB 1002 Balance
`Calibrated Accu-Safe 12" Lab Thermometer (0 - 230 ℉)
`Paper measuring tray
`10 ml Graduated Cylinders
`Clock / Timer
`Glass Stir Rod
`Rubber Stoppers
`High Density PolyEthylene (HDPE) tubing
`
`Foreword:
`All procedures were executed under room temperature (25 ℃) and pressure (1 atm) unless otherwise
`stated. In processing this method of manufacturing the raw materials , sample 2 utilized a 1:1.4 ratio of
`Creatine Monohydrate and HCl gas. Sample 2 was created via HCl gas infusion into Diethyl Ether
`followed by stirring in Creatine Monohydrate. This method detailed in Patent #7,608,641 has been
`shown to produce creatine hydrochloride.
`
`Sample 2: 1 mol CH20: 1.4 mol HCl
`Monohydrate was added incrementally in gram doses to better control the exothermic reaction.
`
`Vireo Systems, Inc. Ex. 2012 – 012
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`
`Vireo Systems, Inc.
`
`
`Procedure for Sample 2:
`1. Put balance under fume hood
`2. Placed paper measuring tray on balance and tared out weight
`3. Weighed out 4.45 grams of Creatine Monohydrate
`4. Poured 5 ml of Diethyl Ether into a 10 ml graduated cylinder
`5. Transferred Diethyl Ether into 125 ml Erlenmeyer Flask
`6. Attached 125 ml Erlenmeyer Flask to Ring stand for stability
`7. Threaded HDPE tube through rubber stopper
`8. Connected HDPE tube from HCl Tank to 125 ml Erlenmeyer flask (with end of tube submerged
`in ether but not touching the bottom of the flask)
`9. Situated flask/ tube combo on the balance and tared weight
`10. Activated Fume hood
`11. Began bubbling in HCl gas until balance read 1.5 gram
`12. Pulled HCl gas tube out of flask and then cut off gas to avoid siphoning back up tube
`13. Turned off Fume Hood
`14. Added Creatine Monohydrate (4.45 gram)
`15. Agitated with glass stir rod for 2 min
`16. Monitored temperature with thermometer (38℃)
`17. Poured mixture onto filter paper in vacuum filtration system
`18. Washed with 5 ml of Diethyl Ether
`19. Let Vaccum Filter (detailed in Method 1) run for 2 minutes
`20. Turned off and let powder dry for 3 hours at room temperature
`21. Weighed dry sample taring out paper measuring tray weight
`
`
`
`Final product was found via NMR spectroscopy to be at least 98 percent or greater pure creatine
`hydrochloride.
`
`
`
`Samples were prepared in sterile packaging for transport to Vanderbilt for purity testing.
`
`
`
`Vireo Systems, Inc. Ex. 2012 – 013
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`Solubility Tests for Creatine HCl
`
`Vireo Systems, Inc.
`
`Materials:
`● 5 gram Creatine HCl synthesized via method 1
`● 5 gram Creatine HCl synthesized via method 2 *
`● 20 ml of Purified Water
`● Fischer Scientific Thermix Stirrer
`● Vacuum Pump
`● 50 ml Pyrex Beakers
`● 500 ml Pyrex Buchner Flask
`● Plastic Scraper
`● Ceramic Mortar and Pestle
`● Highland HCB 1002 Balance (0.00 gram resolution)
`● 5 ml Pyrex Graduated Cylinder
`● Filter Paper
`● Paper Measuring Tray
`● Plastic Perforated Funnel for filtration
`
`*Tests were run across 2 different lab batches of Creatine HCl
`
`Procedure:
`1. Placed paper measuring tray on balance and tared weight
`2. Weighed out 3.75 g of Creatine HCl
`3. Crushed powder very fine with mortar and pestle to best mimic retail product consistency
`4. Measured 5 ml of Purified Water
`5. Combined purified water and Creatine HCl in a 50 ml Beaker
`6. Dropped in magnetic stirring device
`7. Stirred for 2 min
`8. Attached vacuum hose to 500 ml Buchner flask
`9. Placed filter funnel into top of Buchner flask and filter paper into funnel
`10. Poured solution over filter paper
`11. Activated vacuum ( liquid will be pulled into Buchner flask while wet insolubles remained on
`filter paper)
`For 2 minutes (until all liquid has stopped dripping into Buchner flask)
`12. Let sample air dry
`13. Scraped all sample from filter paper onto measuring paper
`14. Weighed sample (Make sure balance has tared out weight of measuring paper)
`
`Vireo Systems, Inc. Ex. 2012 – 014
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`(Original Creatine HCl mass – measured sample remainder ) / volume of purified water = aqueous
`solubility
`(3.75 - .09 ) mg / 5 ml = 732 mg / ml
`
`Vireo Systems, Inc.
`
`Results:
`
`Sample 1: 1 mol CH20: 1.4 mol Acetyl Chloride
`732 mg/ml
`Sample 2: 1 mol CH20: 1.4 mol HCl gas
`664 mg/ml
`
`Vireo Systems, Inc. Ex. 2012 – 015
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947
`
`

`
`EXHIBIT B TO EX. 2012
`
`Vireo Systems, Inc. Ex. 2012 – 016
`
`
`Harvest Trading Group, Inc. v. Vireo Systems, Inc.
`IPR2016-00947

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket